Location History:
- Siegnenfeld, AT (2014)
- Siegenfeld, AT (2016 - 2024)
Company Filing History:
18 out of 46 
7 out of 13 
1 out of 64 Years Active: 2014-2025
Title: Robert Schlegl: Innovator in Virus Research and Vaccine Development
Introduction: Robert Schlegl, based in Siegenfeld, Austria, is a prominent inventor with an impressive portfolio of 25 patents. His work, primarily focused on viral purification processes and vaccine development, has significantly contributed to the field of infectious disease research and prevention.
Latest Patents: Among Schlegl's latest inventions are groundbreaking patents on virus purification. These patents detail novel processes for purifying infectious virus particles, highlighting the crucial role of protamine in these methods. Additionally, he has developed patents related to Zika virus vaccines, outlining innovative compositions and methods for producing and administering these vaccines to individuals in need.
Career Highlights: Throughout his career, Schlegl has worked with notable companies such as Valneva Austria GmbH and Valneva SE. His contributions in these organizations have played a pivotal role in advancing research and development in the biopharmaceutical sector, particularly in vaccine technology.
Collaborations: Schlegl has collaborated with esteemed colleagues, including Michael Weber and Jürgen Heindl-Wruss. These partnerships have facilitated shared knowledge and expertise, further enhancing the innovative projects Schlegl is involved in.
Conclusion: Robert Schlegl stands out as a key figure in the field of viral research and vaccine development. His extensive patent portfolio and collaborative efforts underscore his commitment to advancing medical science and improving public health through innovation.